Myasthenia Gravis Exacerbation Following COVID-19 Vaccine: A Case Report
Background: Vaccination remains the mainstay of strategy for prevention of Coronavirus Disease-2019 (COVID-19). AZD1222 (AstraZeneca vaccine) was distributed in Sudan by the COVID-19 Vaccines Global Access facility in March 2021. It was added to the emergency use list by the WHO in mid-February 202...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
University Library System, University of Pittsburgh
2023-03-01
|
Series: | International Journal of Medical Students |
Subjects: | |
Online Access: | https://ijms.info/IJMS/article/view/1455 |
Search Result 1
Myasthenia Gravis Exacerbation Following COVID-19 Vaccine: A Case Report
Published 2022-12-01
Get full text
Article